Note: We want to make managing your medicine easy
That said, if youre still struggling to sleep after several weeks, its a good idea to check in with your healthcare provider
These trends underscore a rising need for advancements in GLP1 delivery systems and broader patient access initiatives
About the GEMINI-1 Clinical Trial The GEMINI-1 clinical trial was a multi-center, randomized, double-blind, placebo-controlled Phase 3 clinical study (NCT06396429) conducted by Hengrui in China to evaluate the efficacy and safety of HRS9531 injection in adults (18 years of age) with obesity (BMI 28 kg/m 2 ) or overweight (BMI 24 kg/m 2 ) and at least one weight-related comorbidity without diabetes
Combining low-quality compounds with other therapies can cause unpredictable reactions or infections
Sarcopenia Approximately 40% of the weight reduction associated with GLP-1 RAs is derived from a lean body mass, which raises significant concerns regarding its potential negative impact on skeletal muscle functionality [110]